Clinical Trial

Efficacy of MI078 Capsules in Treating Postpartum Depression

Completed Phase 2
View on ClinicalTrials.gov →
Summary
This study is a multicenter, randomized, double-blind, placebo-controlled trial. It includes three groups. Each group will enroll 24 participants. The trial aims todetermine： To evaluate the efficacy of MI078 capsules in treating postpartum depression and to explore the optimal dosing regimen for MI078 capsules. To assess the safety of MI078 capsules in postpartum depression patients.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-06; most recent amendment 2026-06-24.
Status change: Active, Not Recruiting → Completed 2026-06-24
Status change: Recruiting → Active, Not Recruiting 2025-08-25
Trial Details
NCT Number NCT06963580
Lead Sponsor Nanjing Minova Pharmaceutical Co., Ltd.
Conditions Postpartum Depression
Enrollment 72 participants
Start Date 2024-09-09
Primary Completion 2025-08-07 (estimated)
Study Completion 2025-08-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-25